MI risk prediction after noncardiac surgery simplified
ORLANDO – Three conventional cardiovascular risk factors tell the tale.
Galectin-3: A new post-MI prognostic biomarker?
hs-cTnT test tied to fewer reinfarctions but no survival benefit
USPSTF: Don’t add ECG for cardio risk assessment
Evidence is insufficient to assess risks vs. benefits of screening ECG for asymptomatic adults.
DOAC’s edge over warfarin fades with low adherence
Kawasaki disease: New info to enhance our index of suspicion
Now the seasonality trends appear blurred in the youngest cases and the male predominance is blurred in the oldest cases.
Safety of MRI in patients with implantable cardiac devices
Is MRI safe for patients who have implanted ICD or pacemakers that have not been deemed to be “MRI conditional” by the Food and Drug...
LAAC in nonvalvular AF provides stroke protection comparable to warfarin
Is mechanical left atrial appendage closure (LAAC) as effective as warfarin at preventing stroke in patients with nonvalvular atrial fibrillation...
Guidelines to optimize treatment of reduced ejection fraction heart failure
What guidance is there for clinical care of complex heart failure patients?
Long-acting bronchodilators increase CVD risk in certain COPD patients
Is the initiation of inhaled long-acting beta2-agonist (LABA) or long-acting muscarinic antagonists (LAMA) in patients with chronic...